Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today.
Total revenue of $2.5 billion was flat at actual currency and up 1% at constant currency compared to the same period a year ago.
Net income attributable to Biogen Inc. was $583.6 million compared to $591.6 million last year.
GAAP EPS dropped 2% to $4.00 while adjusted EPS rose 31% to $5.28 compared to last year.
For the full year of 2024, the company expects total revenue to decline by a low-single digit percentage. Adjusted EPS is expected to be $15.75-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
GIS Earnings: All you need to know about General Mills’ Q1 2025 earnings results
General Mills, Inc. (NYSE: GIS) reported its first quarter 2025 earnings results today. Net sales decreased 1% year-over-year to $4.8 billion. Organic sales were down 1%. Net earnings attributable to
Guardian Pharmacy seeks to raise up to $108 mil in US IPO
Joining the wave of healthcare IPOs this year, amid Fed rate cut expectations, Guardian Pharmacy Services, Inc. is preparing to go public. In a statement filed with the Securities and
Earnings Preview: Will Micron (MU) maintain recovery momentum in Q4?
After recovering from a rough patch, Micron Technology Inc. (NASDAQ: MU) is preparing to report fourth-quarter results next week, even as the market keeps a close watch on the event
